To Assess If Any 10 Years Cardiovascular Mortality Risk In Patients with Psychiatric Disorders By Using Framingham Risk Score

Abstract

Aim: The aim of the present study was to assess if any 10 years cardiovascular mortality risk in patients with psychiatric disorders by using Framingham risk score. Methods: The cross-sectional study was conducted at Dr. D. Y. Patil Medical College, Hospital and Research centre, Pimpri, Pune from July 2015 to September 2017 and 126 patients were included in the study. Results: The majority of patients 78(61.9%) were in the age group of less than 40 years and there were 48(38.1%) cases who were aged more than 40 years. Majority of cases were females 67(53.2%) and 59(46.8%) cases were males. The association between Framingham risk score with metabolic syndrome showed that patients with metabolic syndrome had a mean value of 10.32 with standard deviation of 5.97 on both sides and in patient who were not having metabolic syndrome mean Framingham risk score was 2.61 with standard deviation of 5.89. A significant difference of Framingham risk score according to metabolic syndrome was found as p value was found to be<.0001. The association between coronary artery heart disease risk with metabolic syndrome showed that in patients who were diagnosed with metabolic syndrome in them 0-5 % risk was seen in 34(72.34%) cases and >5% risk was seen in 13(27,66%) patients. In patients not having metabolic syndrome in 0-5% risk was seen in 73(92.41%) cases and >5 % risk was seen in 6(7.59%) patients. Conclusion: The study suggests that patients suffering from psychiatric disorders are at higher risk of developing metabolic syndrome. The Framingham risk score and 10 years coronary heart disease risk was also found to be higher in these patients. Asian population is already at higher risk to develop metabolic syndrome, routine screening of patients suffering from psychiatric disorder and those who are receiving psychotropics for metabolic disturbances becomes essential.